| Item Type | Name |
|
Concept
|
RNAi Therapeutics
|
|
Concept
|
Combined Modality Therapy
|
|
Concept
|
Genetic Therapy
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Molecular Targeted Therapy
|
|
Academic Article
|
Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer.
|
|
Academic Article
|
Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration.
|
|
Academic Article
|
Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.
|
|
Academic Article
|
Nanoparticle-based cisplatin therapy for cancer.
|
|
Academic Article
|
Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy.
|
|
Academic Article
|
Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment.
|
|
Academic Article
|
Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.
|
|
Academic Article
|
Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.
|
|
Academic Article
|
HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.
|
|
Academic Article
|
Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy.
|
|
Academic Article
|
Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment.
|
|
Academic Article
|
Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy.
|
|
Academic Article
|
Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment.
|
|
Academic Article
|
Tumor-Targeted Dendrimer Nanoparticles for Combinatorial Delivery of siRNA and Chemotherapy for Cancer Treatment.
|
|
Academic Article
|
Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration.
|
|
Academic Article
|
Cytokine- and chemokine-based gene therapy for cancer.
|
|
Academic Article
|
Adenovirus-mediated PTEN treatment combined with caffeine produces a synergistic therapeutic effect in colorectal cancer cells.
|
|
Academic Article
|
Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation.
|
|
Academic Article
|
MDA-7/IL-24-based cancer gene therapy: translation from the laboratory to the clinic.
|
|
Academic Article
|
Targeted drug and gene delivery systems for lung cancer therapy.
|
|
Academic Article
|
Apoptin studies illuminate intersection between lipidomics and tumor suppressors.
|
|
Academic Article
|
mda-7 In combination with bevacizumab treatment produces a synergistic and complete inhibitory effect on lung tumor xenograft.
|
|
Academic Article
|
The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cells.
|
|
Academic Article
|
Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo.
|
|
Academic Article
|
Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
|
|
Academic Article
|
MDA-7/IL-24 suppresses human ovarian carcinoma growth in vitro and in vivo.
|
|
Academic Article
|
Cancer targeting using tumor suppressor genes.
|
|
Academic Article
|
Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans.
|
|
Academic Article
|
Exosomes: a role for naturally occurring nanovesicles in cancer growth, diagnosis and treatment.
|
|
Academic Article
|
HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer.
|
|
Academic Article
|
PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cells.
|
|
Academic Article
|
mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic.
|
|
Academic Article
|
Ectopic production of MDA-7/IL-24 inhibits invasion and migration of human lung cancer cells.
|
|
Academic Article
|
Nanoparticle based systemic gene therapy for lung cancer: molecular mechanisms and strategies to suppress nanoparticle-mediated inflammatory response.
|
|
Academic Article
|
Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated -7 (mda-7)/interleukin-24 (IL-24) gene.
|
|
Academic Article
|
Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients.
|
|
Academic Article
|
Inhibition of nuclear factor-kappaB augments antitumor activity of adenovirus-mediated melanoma differentiation-associated gene-7 against lung cancer cells via mitogen-activated protein kinase kinase kinase 1 activation.
|
|
Academic Article
|
Targeting single-walled carbon nanotubes for the treatment of breast cancer using photothermal therapy.
|
|
Grant
|
An improved IL-24 gene-based therapeutic for cancer
|
|
Grant
|
HuR Targeted Nanotherapy for Lung Cancer
|
|
Grant
|
Evaluate the antiangiogenic properties of mda-7/IL-24
|
|
Grant
|
Systemic Non-Viral Gene Therapy for Cancer
|
|
Grant
|
Preclinical Development and Testing of Multifunctional Tumor-Targeted Hybrid Nano
|
|
Grant
|
Molecular Impact of Platinum Drugs on the Proteasome and SQSTM1_P62 Complexes_A Paradigm Shift in Resistance
|
|
Grant
|
Exosomes as carriers of cancer therapeutics
|
|
Academic Article
|
Drug delivery approaches for HuR-targeted therapy for lung cancer.
|
|
Academic Article
|
Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer.
|
|
Academic Article
|
Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment.
|